Omalizumab: Beyond anti-IgE properties

Perotin, JM; Barnig, C

Perotin, JM (reprint author), Ctr Hosp Univ, Serv Malad Resp, INSERM, UMRS 903, 45 Rue Cognacq Jay, F-51100 Reims, France.

REVUE DES MALADIES RESPIRATOIRES, 2017; 34 (2): 121

Abstract

Introduction. - Omalizumab is used as a treatment for severe allergic asthma. Its intended mechanism of action is based on its anti-IgE proprieties. H......

Full Text Link